Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo

Journal of the American Academy of Dermatology

Volumn 35, Issue 1, 1996, Pages 21-26

  Grimes, Pearl E ^a,c   Sanders Sevall, J ^b   Vojdani, Aristo ^a  

^a KING DREW MEDICAL CENTER   (United States)

^b Specialty Laboratories   (United States)

^c Vitiligo Pigmentation Inst S C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; SKIN BIOPSY; VIRUS PATHOGENESIS; VITILIGO;

EID: 15844377841     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90490-9     Document Type: Article

References (52)

1. Grimes PE. Diseases of hypopigmentation. In: Sams WM, Lynch PJ, editors. Principles and practice of dermatology. 2nd ed. New York: Churchill-Livingstone. 1996:843-57.
2. Shah AS, Supapannachart N, Nordlund JJ. Acquired hypomelanotic disorders. In: Levine N, editor. Pigmentation and pigmentary disorders. Boca Raton, FL: CRC Press, 1993:334-51.
3. Gamble DR, Taylor KW, Gumming H. Coxsackie viruses and diabetes mellitus. Br J Dermatol 1973;4:260-2.
4. Jensen AB, Rosenberg HS, Notkins AL. Pancreatic islet cell damage in children with fatal viral infections. Lancet 1980;2:354-8.
5. Leiter EH, Hamaguchi K. Viruses and diabetes: diabetogenic role for endogenous retroviruses in NOD mice. J Autoimmun 1990;3(suppl):31-40.
6. Schweiger F, Bell DA, Little AH. Coexistence of rheumatoid arthritis in couples: a search for etiological factors. J Rheumatol 1981;8:416-22.
7. Fox R. Epstein-Barr virus and human autoimmune diseases: possibilities and pitfalls. J Virol Methods 1988;21:19-27.
8. Kitagawa H, Ito S, Yakochi T, et al. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol Lett 1988;7:249-52.
9. Yamaoko K, Miyaska N, Yamamoto K. Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjogren's syndrome. Arthritis Rheum 1988;31:1014-21.
10. Frank TS, Li Volsi VA, Connor AM. Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med 1987;60:1-8.
11. Rabsmen PE, Gass DM. Vogt-Koyanagi-Harada syndrome: clinical course, therapy and long-term visual outcome. Arch Opthalmol 1991;10:682-7.
12. Kuswaski N, Kogi H, Kaji M, et al. Lymphocyte subsets in peripheral blood and cerebrospinal fluid in Vogt-Koyanagi-Harada disease. Rinsho Shinkeigaku 1985;25: 956-9.
13. Yokoyama MM, Matsui Y, Yamashiroya HM, et al. Hormonal and cellular immunity with Vogt-Koyanagi-Harada syndrome, Behçet's disease and sympathetic ophthalmia. Ophthalmia 1985;92:1025-8.
14. Duvic M, Rapíni R, Hoots WK, et al. Human immunodeficiency virus-associated vitiligo: Expression of autoimmunity with immunodeficiency? J Am Acad Dermatol 1987;17:656-62.
15. Ivker R, Goldaber M, Buchness MR. Blue vitiligo. J Am Acad Dermatol 1994;30:829-31.
16. Lo AC, Feldman SR. Polymerase chain reaction: basic concepts and clinical applications in dermatology. J Am Acad Dermatol 1994;30:250-60.
17. Barros F, Carracedo A, Lareau MV, et al. Electrophoretic human leukocyte antigen HLA DQA1 DNA typing after polymerase chain reaction amplification. Electrophoresis 1991;12:1041-5.
18. Rogers BB, Josephson SL, Mak SK, et al. Polymerase chain reaction amplification of herpes simplex virus DNA from clinical samples. Obstet Gynecol 1992;79:464-9.
19. Ho M. Cytomegalovirus: biology and infection. 2nd ed. New York: Plenum Publishing, 1991:127-300.
20. Grimes PE, Halder RM, Jones C, et al. Autoantibodies and their clinical significance in a black vitiligo population. Arch Dermatol 1983;119:300-3.
21. Betterle C, Caretti A, DeZio A, et al. Incidence and significance or organ specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 1985;171:419-23.
22. Norris DA, Kissinger M, Naughton GH, et al. Evidence of immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement mediated damage and antibody dependent cell-mediated cytotoxicity (ADCC). J Invest Dermatol 1988; 90:783-9.
23. Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993;100:812-5.
24. Cui J, Harning R, Henn M, et al. Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 1992;98:162-5.
25. Sung YH, Connor E, Yangxin L, et al. The role of tyrosinase in autoimmune vitiligo. Lancet 1994;344:1049-52.
26. Grimes PE, Vojdani A, Wedlow C. Circulating immune complexes in vitiligo [abstract]. Pigment Cell Res 1993; 6:237.
27. Taher UZ-Zaman, Begum S, Waheed MA. In vitro assessment of T lymphocyte functioning in vitiligo. Acta Derm Venereol (Stockh) 1992;72:266-7.
28. Grimes PE, Ghoneum M, Stockton T, et al. T cell profiles in vitiligo. J Am Acad Dermatol 1986;14:196-201.
29. Halder RM, Walters CS, Johnson BA, et al. Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study. J Am Acad Dermatol 1986;14:733-37.
30. Abdel-Naser MB, Ludwig WD, Gollnick H, et al. Non-segmental vitiligo: decrease of the CD45RA+T cell subset and evidence for peripheral T cell activation. Int J Dermatol 1992;31:321-36.
31. Grimes PE, Temple W, Najera D, et al. Lymphoproliferative responses in segmental and non-segmental Vitiligo [abstract]. J Invest Dermatol 1987;88:492.
32. Ghoneum M, Grimes PE, Gill G, et al. Natural cell-mediated cytotoxicity in vitiligo. J Am Acad Dermatol 1987; 17:600-5.
33. Uehara M, Miyauchi H, Tanaka S. Diminished contact sensitivity response in vitiliginous skin. Arch Dermatol 1984;120:195-8.
34. Grimes PE, Indianer L, Pitts E, et al. The histopathological spectrum of vitiligo [abstract]. J Invest Dermatol 1988; 90:564.
35. Gokhale BB, Mehta LN. Histopathology of vitiliginous skin. Int J Dermatol 1983;22:477-80.
36. Grimes PE, Sun H, Loeb LJ, et al. Immunohistochemical characterization of inflammatory cell infiltrates in vitiligo. XTV International Pigment Cell Conference Abstracts, Kobe, Japan, 1990.
37. Halder RM, Walter CS, Johnson BA, et al. Interleukin-2 synthesis is decreased in vitiligo [abstract]. J Invest Dermatol 1987;88:493.
38. Mocarski E. Cytomegalovirus. In: Webster RG, Granoff A, editors. Encyclopedia of virology. San Diego: Academic Press, 1989:292-312.
39. Gnann JW Jr, Ahlnen J, Svalander C, et al. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol 1988;132:239-45.
40. Pereira RA, James DCO, Stern H. Correlation between cytomegalovirus infection and HLA BW15. Br Med J 1978; 2:126-8.
41. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 1988;10(suppl 3):S460-7.
42. Stagno S, Volanakis JE, Reynolds DW, et al. Immune complexes in congenital and natal cytomegalovirus infection of man. J Clin Invest 1977;60:838-45.
43. Theofilopoulos AN. Evaluation and clinical significance of circulating immune complexes. Prog Clin Immunol 1980;4: 63-106.
44. Landini MD, Laazrotto T, Percivalle E, et al. Evidence that human cytomegalovirus assembly protein shares antigenic sites with an uninfected cell membrane protein. J Gen Virol 1991;72:3009-16.
45. Fujinami RS, Nelson JA, Walker L, et al. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR B chain: a means of graft rejection and immunosuppression. J Virol 1988;62:101-5.
46. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC Class I antigens. Nature 1988;331:269-72.
47. Al Badri AM, Foulis AK, Todd PM, et al. Abnormal expression of MHC Class II and ICAM-1 by melanocytes in vitiligo. J Pathol 1993;169:203-6.
48. Pak CY, Ean HM, McArthur RG, et al. Association of cytomegalovirus infection with autoimmune Type I diabetes. Lancet 1988;1:1-4.
49. Pak CY, Cha CY, Rajotte RV, et al. Human pancreatic islet cell specific kilodalton autoantigen identified by cytomegalovirus induced monoclonal islet cell autoantibody. Diabetologica 1990;33:569-72.
50. Ward KP, Galloway WH, Auchterlone IA. Congenital cytomegalovirus infection and diabetes. Lancet 1979;1:497.
51. Murayama J, Jisaki F, Ayata M, et al. Cytomegalovirus genomes demonstrated by polymerase chain reaction in synovial fluid from rheumatoid arthritis patients. Clin Exp Rheumatol 1992;10:161-4.
52. Skinner RB. Alopecia areata and presence of cytomegalovirus DNA [letter]. JAMA 1995;273:1419-20.